Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study (vol 59, pg 239, 2024)

被引：0
|
作者：
Ogawa, Eiichi
Jun, Dae Won
Toyoda, Hidenori
Hsu, Yao-Chun
Yoon, Eileen L.
Ahn, Sang Bong
Yeh, Ming-Lun
Do, Son
Trinh, Huy N.
Takahashi, Hirokazu
Enomoto, Masaru
Kawada, Norifumi
Yasuda, Satoshi
Tseng, Cheng-Hao
Kawashima, Keigo
Lee, Han Ah
Inoue, Kaori
Haga, Hiroaki
Do, Ai-Thien
Maeda, Mayumi
Hoang, Joseph H.
Cheung, Ramsey
Eguchi, Yuichiro
Ueno, Yoshiyuki
Furusyo, Norihiro
Yu, Ming-Lung [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Tanaka, Yasuhito
Nguyen, Mindie H.
机构：
[1] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Hepatitis Res Ctr, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Cohort Res Ctr, Kaohsiung, Taiwan
[4] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan
[5] Natl Sun Yat Sen Univ, Sch Med, Kaohsiung, Taiwan
[6] Natl Sun Yat Sen Univ, Coll Med, Doctoral Program Clin & Expt Med, Kaohsiung, Taiwan
[7] Natl Sun Yat Sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung, Taiwan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 59卷 / 05期
关键词：
D O I：
10.1111/apt.17885
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：725 / 725
页数：1
相关论文
共 50 条
  • [31] Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea
    Kim, Eunju
    Lee, Hyun Woong
    Kim, Soon Sun
    Yoon, Eileen
    Jang, Eun Sun
    Chang, Jong-In
    Cho, Young Youn
    Seo, Gi Hyeon
    Kim, Hyung Joon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1185 - 1193
  • [32] Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study
    Sato, Kosuke
    Inoue, Jun
    Akahane, Takehiro
    Kobayashi, Tomoo
    Sato, Shuichi
    Kisara, Norihiro
    Ninomiya, Masashi
    Iwata, Tomoaki
    Sano, Akitoshi
    Tsuruoka, Mio
    Onuki, Masazumi
    Masamune, Atsushi
    MEDICINE, 2022, 101 (39) : E30630
  • [33] Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
    Farag, Mina S.
    Fung, Scott
    Tam, Edward
    Doucette, Karen
    Wong, Alexander
    Ramji, Alnoor
    Conway, Brian
    Cooper, Curtis
    Tsoi, Keith
    Wong, Philip
    Sebastiani, Giada
    Brahmania, Mayur
    Haylock-Jacobs, Sarah
    Coffin, Carla S.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (06) : 942 - 950
  • [34] EFFECTIVENESS AND SAFETY OF TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B PATIENTS WITH DECOMPENSATED CIRRHOSIS: A REAL-WORLD STUDY IN CHINA
    Guo, Feng
    Ning, Zhonghui
    Wang, Xiaobo
    Xu, Qiang
    Ji, Fanpu
    Yue, Yonghong
    Wang, Zhuanguo
    Dang, Shuangsuo
    Wang, Hongfeng
    Fu, Qiang
    Zeng, Shengtao
    Zuo, Weize
    Zhang, Xinhua
    Wang, Xiaozhong
    HEPATOLOGY, 2022, 76 : S267 - S268
  • [35] EFFECTIVENESS AND SAFETY OF TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B PATIENTS WITH DECOMPENSATED CIRRHOSIS: A REAL- WORLD STUDY IN CHINA
    Dou, Jing
    Guo, Feng
    Ning, Zhonghui
    Wang, Xiaobo
    Xu, Qiang
    Ji, Fanpu
    Yue, Yonghong
    Wang, Zhuanguo
    Dang, Shuangsuo
    Wang, Hongfeng
    Fu, Qiang
    Zeng, Shengtao
    Zuo, Weize
    Zhang, Xinhua
    Wang, Xiaozhong
    HEPATOLOGY, 2024, 80 : S232 - S232
  • [36] Bone Scintigraphy and Tenofovir-Induced Osteomalacia in Chronic Hepatitis B (vol 51, pg 195, 2017)
    Khoo, Alex Cheen Hoe
    Lee, Yeong Fong
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (01) : 71 - 71
  • [37] FRAX SCORE IN THE ASSESSMENT OF BONE MINERAL DENSITY CHANGES IN TENOFOVIR TREATED CHRONIC HEPATITIS B PATIENTS
    Gill, U. S.
    Zissimopoulos, A.
    Al-shamma, S.
    Burke, K.
    McPhail, M.
    Barr, D.
    Ross, V.
    Kallis, Y.
    Kooner, P.
    Marley, R.
    Foster, G. R.
    Kennedy, P. T.
    GUT, 2013, 62 : A190 - A190
  • [38] Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
    Chen, En-Qiang
    Li, Lan-Qing
    Zhou, Jing
    Li, Yu-Jing
    Wang, Fa-Da
    Zhang, Dong-Mei
    Wang, Meng-Lan
    GUT, 2023, 72 (SUPPL_1) : A157 - A159
  • [39] Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
    Li, Lanqing
    Zhou, Jing
    Li, Yujing
    Wang, Fada
    Zhang, Dongmei
    Wang, Menglan
    Tao, Yachao
    Chen, Enqiang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Prospective Assessment Of Frequency And Factors Associated With Bone Loss During Tenofovir Therapy In Patients With Chronic Hepatitis B
    Alawad, Ahmad S.
    Suarez, Daniel F.
    Auh, Sungyoung
    Rivera, Elenita
    Ghany, Marc G.
    HEPATOLOGY, 2017, 66 : 1025A - 1025A
12345